We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$670M
1-Year Est. Return
34.04%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
+34.04%
3 Year Est. Return
+107.53%
5 Year Est. Return
+130.35%
10 Year Est. Return
+379.12%
AUM
$422M
AUM Growth
+$39.5M
(+10%)
Cap. Flow
+$5.79M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
240
New
12
Increased
81
Reduced
118
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$5.19M |
| 2 |
UnitedHealth
UNH
|
+$3.72M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97M |
| 4 |
Dick's Sporting Goods
DKS
|
+$2.42M |
| 5 |
Air Products & Chemicals
APD
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.51M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$1.04M |
| 3 |
Medtronic
MDT
|
+$945K |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$672K |
| 5 |
Corning
GLW
|
+$633K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.31% |
| 2 | Industrials | 12.36% |
| 3 | Healthcare | 11.57% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Boston Scientific
BSX
$75.1B
| $511K | 0.12% |
8,834
+153
| +2% | +$8.17K |
|
127
Phillips 66
PSX
$93.2B
| $507K | 0.12% |
3,807
+8
| +0.2% | +$956 |
|
128
Blackrock
BLK
$182B
| $500K | 0.12% |
616
+6
| +1% | +$4.19K |
|
129
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $496K | 0.12% |
5,150
-327
| -6% | -$30.2K |
|
130
Monster Beverage
MNST
$91.7B
| $494K | 0.12% |
17,166
-2,530
| -13% | -$67.6K |
|
131
iShares US Technology ETF
IYW
$25.6B
| $494K | 0.12% |
4,025
-236
| -6% | -$26.7K |
|
132
Vanguard S&P 500 ETF
VOO
$1.04T
| $488K | 0.12% |
1,116
+2
| +0.2% | +$819 |
|
133
Lamb Weston
LW
$7.3B
| $484K | 0.11% |
4,475
-1,108
| -20% | -$107K |
|
134
Everest Group
EG
$14.2B
| $481K | 0.11% |
1,360
-181
| -12% | -$70.1K |
|
135
Molson Coors Class B
TAP
$7.97B
| $478K | 0.11% |
7,802
-1,213
| -13% | -$72.9K |
|
136
VICI Properties
VICI
$29B
| $477K | 0.11% |
14,953
-2,310
| -13% | -$67.8K |
|
137
Synopsys
SNPS
$80.7B
| $470K | 0.11% |
912
-145
| -14% | -$74.1K |
|
138
Vanguard Information Technology ETF
VGT
$150B
| $467K | 0.11% |
7,728
-312
| -4% | -$17.4K |
|
139
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.4B
| $456K | 0.11% |
4,163
| – | – |
|
140
Gilead Sciences
GILD
$172B
| $454K | 0.11% |
5,608
-999
| -15% | -$77.7K |
|
|
NVO
141
Novo Nordisk
NVO
$201B
| $446K | 0.11% |
4,314
| – | – |
|
142
Morgan Stanley
MS
$342B
| $415K | 0.1% |
4,447
-1,402
| -24% | -$112K |
|
143
Chipotle Mexican Grill
CMG
$42.4B
| $407K | 0.1% |
8,900
-1,500
| -14% | -$62.4K |
|
144
Aflac
AFL
$60.9B
| $404K | 0.1% |
4,897
-92
| -2% | -$7.41K |
|
145
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $398K | 0.09% |
7,867
+377
| +5% | +$18.3K |
|
146
Las Vegas Sands
LVS
$29.9B
| $395K | 0.09% |
8,024
-1,508
| -16% | -$71.3K |
|
147
Cencora
COR
$59.9B
| $393K | 0.09% |
1,913
-29
| -1% | -$5.66K |
|
148
iShares Global Tech ETF
IXN
$9.42B
| $393K | 0.09% |
5,759
-422
| -7% | -$26.5K |
|
149
Hershey
HSY
$37B
| $387K | 0.09% |
2,076
-352
| -14% | -$66.7K |
|
150
Mastercard
MA
$499B
| $387K | 0.09% |
907
| – | – |
|
Similar funds
TAP
CCM
BCP
AVM
FAM
MCO
CCG
PAI
Strategy Asset Managers's Q4 2023 Portfolio in Review
As of Q4 2023, Strategy Asset Managers held 240 positions worth $422M, up 10% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Strategy Asset Managers's Q4 2023 filing shows 12 new, 81 increased, 118 reduced and 12 closed positions. Its largest new stake was Dick's Sporting Goods: 19,908 shares worth $2.93M. The largest sale was Pfizer, an estimated $5.51M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- Strategy Asset Managers's largest Q4 2023 buy was Dick's Sporting Goods: 19,908 shares worth $2.93M.
- Strategy Asset Managers added most to Eli Lilly in Q4 2023, an estimated $5.19M increase.
- Strategy Asset Managers's biggest Q4 2023 reduction was Pfizer, cutting an estimated $5.51M.
- Strategy Asset Managers fully exited iShares US Medical Devices ETF in Q4 2023, selling an estimated $1.04M.
- Strategy Asset Managers's ten largest holdings make up 30% of its $422M portfolio in Q4 2023.
- Strategy Asset Managers opened 12 new positions and closed 12 in Q4 2023.
- Strategy Asset Managers's portfolio value rose 10% quarter-over-quarter to $422M.
Based on Strategy Asset Managers's 13F filing for Q4 2023, filed 12 Feb 2024.